Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Sportradar Group AG (NASDAQ:SRAD)("Sportradar" or the "Company") today announced that Craig Felenstein has been...
Morgan Stanley analyst Connor Lynagh maintains Sportradar Gr (NASDAQ:SRAD) with a Equal-Weight and raises the price target f...
Sportradar (NASDAQ:SRAD) and Oddin.gg, an award-winning B2B betting-solutions provider for esports, today announced they have e...
Jefferies analyst David Katz maintains Sportradar Gr (NASDAQ:SRAD) with a Hold and raises the price target from $10 to $13.
Citigroup analyst Jason Bazinet maintains Sportradar Gr (NASDAQ:SRAD) with a Buy and raises the price target from $15 to $17.
Canaccord Genuity analyst Michael Graham reiterates Sportradar Gr (NASDAQ:SRAD) with a Buy and maintains $16 price target.
JP Morgan analyst David Karnovsky maintains Sportradar Gr (NASDAQ:SRAD) with a Overweight and raises the price target from $...
Needham analyst Bernie McTernan maintains Sportradar Gr (NASDAQ:SRAD) with a Buy and raises the price target from $15 to $16.
Shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR) fell sharply during Wednesday’s session after the company announced it con...
